Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Advances in Hematology|December 5, 2009
Does adiponectin act as an antiangiogenic factor in B-cell chronic lymphocytic leukemia?Stefano Molica, Giovanna Digiesi, Angelo Vacca, et al.
Leukemia & Lymphoma|January 19, 2008
Serum thrombopoietin compared with ZAP-70 and immunoglobulin heavy-chain gene mutation status as a predictor of time to first treatment in early chronic lymphocytic leukemiaStefano Molica, Gaetano Vitelli, Giovanna Cutrona, et al.
Leukemia Research|May 9, 2007
Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemiaStefano Molica, Giovanna Cutrona, Gaetano Vitelli, et al.
Haematologica|September 5, 2007
Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemiaStefano Molica, Marco Montillo, Domenico Ribatti, et al.
Haematologica|October 26, 2010
Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working groupStefano Molica, Francesca R Mauro, Diana Giannarelli, et al.
American Journal of Clinical Oncology|December 1, 2005
Irinotecan (CPT-11) and mitomycin-C (MMC) as second-line therapy in advanced gastric cancer: a phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106)Francesco Giuliani, Stefano Molica, Evaristo Maiello, et al.
Haematologica|November 12, 2009
The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experienceStefano Molica, Francesca R Mauro, Vincenzo Callea, et al.
European Journal of Haematology|May 21, 2003
Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemiaStefano Molica, Gaetano Vitelli, Domenico Levato, et al.
Expert Review of Hematology|September 3, 2013
Treatment of elderly patients with chronic lymphocytic leukemia: an unmet cinical needStefano Molica, Maura Brugiatelli, Fortunato Morabito, et al.
Leukemia Research|June 17, 2008
Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Francesca Mauro, et al.
Pageof 16